Literature DB >> 1579976

Quantal bioassay and stroke.

J A Zivin1, D R Waud.   

Abstract

BACKGROUND: Experimental investigation of stroke, in particular the evaluation of therapeutic maneuvers, is difficult because even well-controlled experiments show considerable variability. Optimal use of resources requires efficient statistical analysis. SUMMARY OF REVIEW: A body of experience in pharmacology that is directly applicable to stroke studies is reviewed. The general approach, though well known to pharmacologists, is less familiar to neurologists. This paper attempts to give a survey so that neurologists encountering studies using this general class of analysis will better be able to put the technique into context. The general nature of a quantal bioassay is described, the underlying conceptual models are discussed, and specific examples are given.
CONCLUSIONS: The pharmacologist's approach to the analysis of quantal bioassays can easily be adapted to the quantification of results in studies of stroke.

Entities:  

Mesh:

Year:  1992        PMID: 1579976     DOI: 10.1161/01.str.23.5.767

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

2.  Dietary supplementation with sodium nitrite can exert neuroprotective effects on global cerebral ischemia/reperfusion in mice.

Authors:  Takasuke Fukuda; Manabu Kakinohana; Chitoshi Takayama; Masayuki Matsushita; Kazuhiro Sugahara
Journal:  J Anesth       Date:  2015-01-08       Impact factor: 2.078

3.  Transcranial motor-evoked potentials monitoring can detect spinal cord ischemia more rapidly than spinal cord-evoked potentials monitoring during aortic occlusion in rats.

Authors:  Manabu Kakinohana; Seiya Nakamura; Tatsuya Fuchigami; Kazuhiro Sugahara
Journal:  Eur Spine J       Date:  2006-06-28       Impact factor: 3.134

4.  Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke.

Authors:  Paul A Lapchak; David R Schubert; Pamela A Maher
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

5.  Delayed paraplegia after spinal cord ischemic injury requires caspase-3 activation in mice.

Authors:  Manabu Kakinohana; Kotaro Kida; Shizuka Minamishima; Dmitriy N Atochin; Paul L Huang; Masao Kaneki; Fumito Ichinose
Journal:  Stroke       Date:  2011-06-23       Impact factor: 7.914

6.  Three variations in rabbit angiographic stroke models.

Authors:  William C Culp; Sean D Woods; Aliza T Brown; John D Lowery; Leah J Hennings; Robert D Skinner; Michael J Borrelli; Paula K Roberson
Journal:  J Neurosci Methods       Date:  2012-11-08       Impact factor: 2.390

7.  A novel approach to screening for new neuroprotective compounds for the treatment of stroke.

Authors:  Pamela Maher; Karmen F Salgado; Justin A Zivin; Paul A Lapchak
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

8.  Synergistic Effect of AJW200, a von Willebrand Factor Neutralizing Antibody with Low Dose (0.9 mg/mg) Thrombolytic Therapy Following Embolic Stroke in Rabbits.

Authors:  Paul A Lapchak; Sarina Doyan; Xiaomin Fan; Catherine M Woods
Journal:  J Neurol Neurophysiol       Date:  2013-04-01

Review 9.  How fisetin reduces the impact of age and disease on CNS function.

Authors:  Pamela Maher
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

Review 10.  Preventing and Treating Neurological Disorders with the Flavonol Fisetin.

Authors:  Pamela Maher
Journal:  Brain Plast       Date:  2021-02-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.